EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage…
April 11, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio…
April 07, 2025 17:00 ET | Source: Anika Therapeutics Inc. BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics,…
April 04, 2025 16:05 ET | Source: Syndax Pharmaceuticals, Inc. NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals…
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…
April 04, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics,…
STRASBOURG, France, April 2, 2025 /PRNewswire/ -- To pioneer new frontiers in life science research, the Human Frontier Science Program…
April 02, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.…
BENGALURU, India, April 1, 2025 /PRNewswire/ -- Give Grants, India's leading platform for CSR solutions, has released in-depth recent research…
LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…
